Insider Buying: Bioventix (LON:BVXP) Insider Acquires 534 Shares of Stock

Bioventix PLC (LON:BVXP – Get Free Report) insider Bruce Hiscock purchased 534 shares of Bioventix stock in a transaction dated Wednesday, June 24th. The shares were bought at an average price of GBX 1,799 per share, for a total transaction of £9,606.66.

Bruce Hiscock also recently made the following trade(s):

Get Bioventix alerts:

• On Monday, April 27th, Bruce Hiscock purchased 66 shares of Bioventix stock. The shares were acquired at an average price of GBX 1,679 per share, with a total value of £1,108.14.

Bioventix Stock Down 5.0%

Shares of BVXP traded down GBX 90 during trading on Wednesday, reaching GBX 1,710. 38,243 shares of the company traded hands, compared to its average volume of 10,349. The stock has a market cap of £89.35 million, a PE ratio of 12.17 and a beta of 0.55. The stock has a 50-day simple moving average of GBX 1,697.30 and a 200-day simple moving average of GBX 1,695.99. Bioventix PLC has a twelve month low of GBX 1,300 and a twelve month high of GBX 3,020.

Bioventix (LON:BVXP – Get Free Report) last released its earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share for the quarter. The company had revenue of GBX 615.88 billion during the quarter. Bioventix had a return on equity of 65.83% and a net margin of 59.30%. On average, equities research analysts predict that Bioventix PLC will post 166.3066955 EPS for the current year.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

See Also

• Five stocks we like better than Bioventix
• Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
• Tesla’s New NHTSA Probe Lands at the Worst Possible Time
• Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
• EVs Are Big Winners of the Iran War—Just Not American Ones

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.